Blood cancers, Myeloma
Results
Phase 2
This trial looked at bortezomib with chemotherapy for people with newly diagnosed amyloidosis. It was supported by Cancer Research UK.
Recruitment start: 15 March 2012
Recruitment end: 1 December 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ashutosh Wechalekar
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/09/027.
Last reviewed: 26 March 2019
CRUK internal database number: 4272
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
